Publications by authors named "Yuya Ohtsuki"

Claim this Profile
R
Reduction of Proportion of Process-Bearing Phenotype of Microglial Cell Line MG6 by Arachidonic Acid Generated From Exogenous Lysophosphatidylinositol.
Kohei Kawabata, Saori Nonaka, Makoto Hirano, Yuya Ohtsuki, Masanori Inagaki

Lipids· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ammonium fluoride as a mobile phase additive on quantitativity of fatty acids in electrospray ionization-liquid chromatography-tandem mass spectrometry.
Kohei Kawabata, Haruka Muraoka, Yuya Ohtsuki, Soo Takasu, Yukihiro Esaka

Anal Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory Effects of Lysophospholipids on Survival and Interleukin-8 Secretion of HT-29, a Human Colon Cancer-Derived Epithelial Cell.
Yuya Ohtsuki, Erena Nakamura, Moe Asakami, Rena Morikawa, Akira Tokumura

Biol Pharm Bull· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced expression of Cyp17a1 and production of DHEA-S in the liver of late-pregnant rats.
Yuya Ohtsuki, Jumpei Fujiki, Naoyuki Maeda, Hidetomo Iwano

Gen Comp Endocrinol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation of Ad4BP/SF-1 suppresses Cyp11a1 and StAR transcripts in C2C12 myoblasts.
Jumpei Fujiki, Naoyuki Maeda, Kosuke Yamaguchi, Yuya Ohtsuki, Hidetomo Iwano

Mol Cell Endocrinol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of hyperoxic cell culture system for predicting drug-induced liver injury: reducing accumulated lipids in hepatocytes derived from chimeric mice with humanized liver.
Yuya Ohtsuki, Seigo Sanoh, Mikaru Yamao, Yuha Kojima, Yaichiro Kotake

J Toxicol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives.
Yuya Ohtsuki, Seigo Sanoh, Masataka Santoh, Yoko Ejiri, Shigeru Ohta

Biochem Biophys Res Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetaminophen analog N-acetyl-m-aminophenol, but not its reactive metabolite, N-acetyl-p-benzoquinone imine induces CYP3A activity via inhibition of protein degradation.
Masataka Santoh, Seigo Sanoh, Yuya Ohtsuki, Yoko Ejiri, Yaichiro Kotake

Biochem Biophys Res Commun· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis